Clik here to view.
U.S. FDA Accepts First Digital Medicine New Drug Application for Otsuka and...
TOKYO & REDWOOD CITY, Calif. Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health (Proteus) today announced that the United States Food and Drug Administration (FDA) has...
View ArticleClik here to view.
ProtoKinetix’ AAGP™ to Be Presented at the Congress of the International...
ST. MARYS, W. Va. ProtoKinetix, Incorporated (OTC: PKTX) (the “Company” or “ProtoKinetix”) (www.protokinetix.com) is pleased to announce that AAGP™ will be presented at the 2015 Joint Congress of...
View ArticleClik here to view.
The World Egg Bank Now Offers the Most Advanced Genetic Testing Available in...
PHOENIX The World Egg Bank Inc. has announced the first testing of banked egg donors and recipients to reduce the incidence of having a child with a genetic disease. The World Egg Bank has partnered...
View ArticleClik here to view.
Jubilant DraxImage Signs Term Sheet with Cyclopharm for Exclusive License to...
MONTREAL & SYDNEY Jubilant DraxImage Inc. (“DraxImage”) and Cyclopharm Limited (“CYC”) are pleased to announce the signing of a term sheet, subject to satisfactory due diligence and execution of...
View ArticleClik here to view.
Takeda Joins WIPO Re:Search to Accelerate R&D of New Drugs for Neglected...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced its participation in WIPO Re:Search, a consortium to accelerate research and development (R&D) of new drugs,...
View ArticleClik here to view.
武田薬品が熱帯病治療薬等の研究開発促進に向けたWIPO Re:Searchへの加盟について発表
大阪 （ビジネスワイヤ） — 当社は、このたび、世界知的所有権機関（WIPO）が主催する、「顧みられない熱帯病（NTD）」、マラリア、結核の治療薬・ワクチン・診断薬の研究開発を促進させるための共同事業体である「WIPOリサーチコンソーシアム（以下、「WIPO Re:Search」）」に加盟しましたのでお知らせいたします。WIPO...
View ArticleClik here to view.
PeptiDream Announces Peptide Discovery Collaboration Agreement with Sanofi
TOKYO PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) today announced a multi-target discovery and optimization collaboration with Sanofi, Paris, France...
View ArticleClik here to view.
米FDA、再発性／難治性多発性骨髄腫患者に対する武田薬品のイキサゾミブに優先審査の指定を与える
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ）– 武田薬品工業株式会社（TSE: 4502）は本日、米食品医薬品局（FDA）がイキサゾミブの新薬承認申請（NDA）に優先審査の指定を与えたと発表しました。イキサゾミブは再発性もしくは難治性または両方の多発性骨髄腫を抱える患者の治療を目的とする初の経口プロテアソーム阻害薬としての治験薬です。...
View ArticleClik here to view.
Physio-Control to Acquire HeartSine®
REDMOND, Wash. Physio-Control has reached an agreement with HeartSine Technologies to acquire the Northern Ireland-based automated external defibrillator (AED) manufacturer, the companies announced...
View ArticleClik here to view.
Shiseido’s Social Business Model in Bangladesh Recognized as Initiative of...
TOKYO Shiseido’s activity in Bangladesh to improve social status and lifestyle of rural women by skincare products was recognized as “Business Call to Action*1 (hereinafter, “BCtA”)” led by the...
View ArticleClik here to view.
武田加入WIPO Re:Search，以加快针对被忽视的热带疾病、疟疾和结核病的新药研发
日本大阪 (美国商业资讯)–武田药品工业株式会社(TOKYO:4502)今天宣布加入WIPO Re:Search联盟，以加快针对被忽视的热带疾病、疟疾和结核病(TB)的新药、疫苗和诊断试剂的研发。WIPO Re:Search旨在通过加大合作来促进产品开发，同时做出切实的贡献，来加强发展中国家的医疗保健基础。 武田药品可及性总监Isabel...
View ArticleClik here to view.
摩根大通携员工为缓解欧洲难民危机捐款最多200万美元
纽约 (美国商业资讯)–摩根大通公司今日宣布，为了向难民提供迅速援助并帮助缓解欧洲难民危机，其基金会将携公司员工提供最多200万美元的捐款。摩根大通基金会将拨款100万美元用于支持拯救儿童基金会(Save the Children)、国际乐施会(Oxfam)、国际救援委员会(International Rescue Committee)与国际医疗队(International Medical...
View ArticleClik here to view.
Jubilant DraxImage与 Cyclopharm签署排他性授权条款清单，在美国推广Technegas
蒙特利尔和悉尼 — (美国商业资讯) — Jubilant DraxImage Inc. (“DraxImage”)与Cyclopharm Limited (“CYC”)欣然宣布签署一份条款清单，DraxImage获得在美国推广和分销Technegas 的排他性授权，该清单有待确定性协议得到满意的尽职调查和执行，以及其他必要的审批。DraxImage将协助CYC开展...
View ArticleClik here to view.
Jubilant DraxImage、米国でTechnegasを上市するための独占的ライセンスの条件規定書をCyclopharmと取り交わす
モントリオール & シドニー — （ビジネスワイヤ） — Jubilant DraxImage Inc.（以下「DraxImage」）とCyclopharm...
View ArticleClik here to view.
ファインデックス、企業・医療機関の両方で利用可能なストレスチェックシステムを販売開始
愛媛県松山市 （ビジネスワイヤ） — 株式会社ファインデックス（東証一部：3649 本社：愛媛県松山市三番町4-9-6 社長：相原輝夫）は、2015年9月16日より「DocuMaker ストレスチェックシステム」を販売いたします。...
View ArticleClik here to view.
Ranken Jordan Pediatric Bridge医院将该院的监护仪升级为搭载 Masimo SET®脉搏氧饱和度仪的Radical-7
密苏里州马里兰高地和加州尔湾 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，Ranken Jordan Pediatric Bridge医院已将该院的监护仪升级为搭载 Masimo SET®脉搏氧饱和度仪的Radical-7 。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
Clik here to view.
Mitobridge Announces Sponsored Research Agreement to Evaluate PPARδ Compounds...
CAMBRIDGE, Mass. Mitobridge, Inc., a biopharmaceutical company pioneering the discovery and development of products that improve mitochondrial function, announces the signing of a sponsored research...
View ArticleClik here to view.
Cigna Foundation Renews World of Difference Grant to Samahope
BLOOMFIELD, Conn. The Cigna Foundation today announced it will renew its World of Difference grant for $150,000 to Samahope, a non-profit that funds treatments for those who otherwise would not have...
View ArticleClik here to view.
Physio-Control收购HeartSine®
华盛顿州雷德蒙德 (美国商业资讯)–Physio-Control与总部在北爱尔兰的自动体外除颤仪(AED)制造商HeartSine Technologies今天宣布，已就前者收购后者达成协议。这两家私有公司近期完成了尽职调查。此次交易的财务细节并未披露。此次合并使之成为世界上最大的AED解决方案提供商之一。 Smart News...
View Article